We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$81B
AUM Growth
+$1.17B
(+1.5%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
26.64%
Holding
1,562
New
88
Increased
546
Reduced
606
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$258M |
| 2 |
Brookfield Asset Management
BAM
|
+$211M |
| 3 |
Atlassian
TEAM
|
+$197M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$190M |
| 5 |
Progressive
PGR
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$396M |
| 2 |
Tesla
TSLA
|
+$335M |
| 3 |
Amazon
AMZN
|
+$310M |
| 4 |
Brookfield
BN
|
+$284M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.44% |
| 2 | Technology | 17.09% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 8.45% |
| 5 | Energy | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
HEICO Corp
HEI
$49.8B
| $446K | ﹤0.01% |
2,904
| – | – |
|
1302
Prime Medicine
PRME
$527M
| $444K | ﹤0.01% |
+23,922
| New | +$432K |
|
1303
Ginkgo Bioworks
DNA
$528M
| $441K | ﹤0.01% |
6,523
| – | – |
|
1304
Bentley Systems
BSY
$10.8B
| $440K | ﹤0.01% |
11,893
-1,000
| -8% | -$36.2K |
|
1305
Medifast
MED
$109M
| $438K | ﹤0.01% |
+3,800
| New | +$442K |
|
|
OBE
1306
Obsidian Energy
OBE
$716M
| $434K | ﹤0.01% |
65,456
+4,456
| +7% | +$34.6K |
|
|
AXON
1307
Axon Enterprise
AXON
$42.5B
| $427K | ﹤0.01% |
+2,571
| New | +$406K |
|
1308
Liberty Global Class C
LBTYK
$3.53B
| $423K | ﹤0.01% |
21,774
-1,300
| -6% | -$24.6K |
|
1309
Diodes
DIOD
$3.78B
| $419K | ﹤0.01% |
5,500
| – | – |
|
1310
Chewy
CHWY
$9.25B
| $416K | ﹤0.01% |
11,212
+528
| +5% | +$20.6K |
|
|
AZPN
1311
DELISTED
Aspen Technology Inc
AZPN
| $415K | ﹤0.01% |
+2,020
| New | +$469K |
|
1312
Definitive Healthcare
DH
$72M
| $413K | ﹤0.01% |
37,540
| – | – |
|
1313
Dutch Bros
BROS
$9.03B
| $408K | ﹤0.01% |
14,488
| – | – |
|
|
SWTX
1314
DELISTED
SpringWorks Therapeutics
SWTX
| $406K | ﹤0.01% |
15,616
| – | – |
|
1315
Western Union
WU
$1.98B
| $404K | ﹤0.01% |
29,318
+700
| +2% | +$9.66K |
|
|
BCPC
1316
Balchem Corp
BCPC
$5.38B
| $403K | ﹤0.01% |
3,300
| – | – |
|
1317
Preferred Bank
PFBC
$1.24B
| $403K | ﹤0.01% |
+5,400
| New | +$394K |
|
|
SVM
1318
Silvercorp Metals
SVM
$2.07B
| $403K | ﹤0.01% |
137,104
+4,236
| +3% | +$11.5K |
|
1319
Movado Group
MOV
$849M
| $400K | ﹤0.01% |
+12,400
| New | +$396K |
|
1320
Green Dot
GDOT
$743M
| $397K | ﹤0.01% |
+25,100
| New | +$463K |
|
1321
Clearwater Paper
CLW
$339M
| $397K | ﹤0.01% |
+10,500
| New | +$409K |
|
|
LKFT
1322
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $395K | ﹤0.01% |
8,900
| – | – |
|
1323
REX American Resources
REX
$1.42B
| $382K | ﹤0.01% |
+24,000
| New | +$362K |
|
1324
Ardelyx
ARDX
$1.22B
| $381K | ﹤0.01% |
+133,600
| New | +$226K |
|
|
INFN
1325
DELISTED
Infinera Corporation Common Stock
INFN
| $380K | ﹤0.01% |
56,390
+27,366
| +94% | +$166K |
|
Similar funds
VAM
TD Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, TD Asset Management held 1,562 positions worth $81B, up 1.5% from $79.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management's Q4 2022 filing shows 88 new, 546 increased, 606 reduced and 117 closed positions. Its largest new stake was Brookfield Asset Management: 7,008,054 shares worth $201M. The largest sale was Alphabet (Google) Class C, an estimated $396M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
- TD Asset Management's largest Q4 2022 buy was Brookfield Asset Management: 7,008,054 shares worth $201M.
- TD Asset Management added most to iShares MSCI Japan ETF in Q4 2022, an estimated $258M increase.
- TD Asset Management's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $396M.
- TD Asset Management fully exited Corcept Therapeutics in Q4 2022, selling an estimated $25.4M.
- TD Asset Management's ten largest holdings make up 27% of its $81B portfolio in Q4 2022.
- TD Asset Management opened 88 new positions and closed 117 in Q4 2022.
- TD Asset Management's portfolio value rose 1.5% quarter-over-quarter to $81B.
Based on TD Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.